Kala Pharmaceuticals Adds 6% In Morning Trade

On:

Shares of Kala Pharmaceuticals, Inc. (KALA) are rising more than 6% Friday morning at $16.43.

The company today said Combangio, Inc., a unit of Kala, has been awarded a $15 million grant by the California Institute for Regenerative Medicine (CIRM) to support the company’s ongoing study of KPI-012 for the treatment of persistent corneal epithelial defect (PCED).

KALA has traded in the range of $3.54-$56.72 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Between Buoyant Earnings And Worrying Geopolitics – World Markets At This Hour
  2. Quoin Pharmaceuticals Up 28% On Plans To Start Second Trial To Evaluate QRX003 Topical Lotion
  3. $BTC: Satoshi Action Fund CEO on Bitcoin: ‘$1,000,000 May Be Just the Beginning’
  4. Rate Hike Fears Dampen Market Sentiment
  5. On Holding Slips 8% In Spite Of Increased Profit, Sales